Skip to main content
. 2023 Dec 7;16:5763–5777. doi: 10.2147/IJGM.S437800

Table 1.

Comparison of General Data Between LRTIs and Non-LRTIs

LRTIs (n = 149) Non-LRTIs (n = 39) P
Age, mean (range), years 60 (51, 69) 59 (50, 69) 0.785
Sex, female, n (%) 32.2 33.3 1.000
Underlying disease, n (%) 83.9 59.0 0.001
Antibiotic use before mNGS, n (%) 75.2 53.8 0.011
White blood cell count, 109/L 7.50 (5.55, 11.00) 8.10 (5.70, 10.20) 0.772
White blood cell count, >9.5×109/L 31.5 41.0 0.341
Neutrophil count, 109/L 5.50 (3.55, 8.80) 5.50 (3.60, 8.70) 0.917
Neutrophil count, >6.3×109/L 40.9 41.0 1.000
C-reactive protein, mg/L 36.08 (3.69, 106.54) 4.29 (0.50, 29.67) < 0.001
C-reactive protein, >10 mg/L 66.9 43.6 0.010
Procalcitonin, ng/mL 0.09 (0.04, 0.27) 0.05 (0.03, 0.09) 0.003
Procalcitonin, >0.05 ng/mL 65.7 50.0 0.087

Notes: Data are presented as n (%) or mean (range). Significance was determined by Chi-square test or non-parametric rank sum test.

Abbreviations: LRTIs, lower respiratory tract infections; mNGS, metagenomic next-generation sequencing.